Radcliffe Capital Management’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-550,397
Closed -$5.47M 1101
2021
Q3
$5.47M Hold
550,397
0.16% 107
2021
Q2
$5.44M Buy
+550,397
New +$5.44M 0.17% 109